Clinical trial

The Effect of Opioid-free Anesthesia on Hemodynamic Response and Nociception Level Index During Laryngoscopy and Intubation

Name
548/02-02-2024
Description
The aim of this study will be to investigate the effect of opioid-free induction versus opioid-based induction on hemodynamic response and nociception level index during elective operations
Trial arms
Trial start
2024-03-20
Estimated PCD
2025-03-20
Trial end
2025-03-20
Status
Recruiting
Treatment
ketamine-lidocaine-dexmedetomidine
Patients will be administered 0,8 mcg/kg Dexmedetomidine in 100 mL of normal saline within 10 minutes as premedication. Followingly, they will receive 1mL/10 kg of the solution containing ketamine, lidocaine and dexmedetomidine at predefined concentrations just before induction of anesthesia.
Arms:
ketamine-lidocaine-dexmedetomidine group
Other names:
KLD group
fentanyl
Patients will be administered 2 mcg/kg fentanyl in 100 mL of normal saline within 10 minutes as premedication. Followingly, they will receive 1mL/10 kg of normal saline solution 0.9% just before induction of anesthesia.
Arms:
fentanyl group
Other names:
control group
Size
60
Primary endpoint
change from baseline in systolic arterial pressure after premedication
30 seconds after premedication
change from baseline in systolic arterial pressure immediately after premedication
immediately after intubation
change from baseline in systolic arterial pressure 1 minute after intubation
1 minute after intubation
change from baseline in systolic arterial pressure 3 minutes after intubation
3 minutes after intubation
change from baseline in systolic arterial pressure 5 minutes after intubation
5 minutes after intubation
change from baseline in diastolic arterial pressure after premedication
30 seconds after premedication
change from baseline in diastolic arterial pressure 1 minute after intubation
1 minute after intubation
change from baseline in diastolic arterial pressure 3 minutes after intubation
3 minutes after intubation
change from baseline in diastolic arterial pressure 5 minutes after intubation
5 minutes after intubation
change from baseline in heart rate after premedication
30 seconds after premedication
change from baseline in heart rate 1 minute after intubation
1 minute after intubation
change from baseline in heart rate 3 minutes after intubation
3 minutes after intubation
change from baseline in heart rate 5 minutes after intubation
5 minutes after intubation
ST segment change 1 minute post intubation
1 minute after intubation
ST segment change 3 minutes post intubation
3 minutes after intubation
ST segment change 5 minutes post intubation
5 minutes after intubation
duration of nociception level<25 for a 5-minute period after intubation
5 minutes after intubation
time required to achieve a train-of four-ratio of 0
within 2.5 minutes of neuromuscular blocking agent administration
Eligibility criteria
Inclusion Criteria: * adult patients * American Society of Anesthesiologists (ASA) classification I-II * Mallampati classification 1, 2 or 3 Exclusion Criteria: * anticipated difficult airway (Mallampati 4 classification, thyromental distance \< 6 cm, mouth opening \< 3 cm, neck extension\< 80 * atrioventricular block * bradycardia (heart rate less than 55/min) * preadministration of beta-blockers * eligibility for rapid-sequence induction * chronic use of opioid medications * known allergy to induction agents * history of psychiatric disease * language or communication barriers or lack of informed consent
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'PREVENTION', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 60, 'type': 'ESTIMATED'}}
Updated at
2024-06-18

1 organization

1 product

1 drug

5 indications

Indication
Anesthesia
Indication
Opioid Use
Indication
Analgesic
Indication
Fentanyl